Jakafi 10Mg Tablets In Pakistan
Jakafi 10Mg Tablets Price In Pakistan Contain Ruxolitinib 10Mg, A Prescription Janus Kinase (Jak) Inhibitor Used To Treat Selected Blood Disorders Such As Myelofibrosis, Polycythemia Vera, And Certain Cases Of Graft-versus-host Disease (Gvhd). It Should Only Be Used Under The Supervision Of A Qualified Hematologist Or Oncologist.
| Payment | Cash on Delivery · Bank Transfer · JazzCash |
| Shipping | Leopard Courier / TCS Courier (2-5 Days) |
| Imported From / Made In | USA |
| Product Size | 60 Tablets |
Jakafi 10Mg Tablets In Pakistan
Jakafi 10Mg Tablets contain Ruxolitinib, a Janus kinase (JAK) inhibitor used under medical supervision for certain blood and immune system disorders. It works by blocking JAK1 and JAK2 pathways, which are involved in blood cell production and immune responses. Jakafi is commonly prescribed for conditions such as myelofibrosis, polycythemia vera (in patients with inadequate response to hydroxyurea), and certain graft-versus-host disease cases. Jakafi 10Mg helps manage disease symptoms by reducing abnormal blood cell activity, controlling inflammation-related signaling, and improving symptoms associated with these conditions. Treatment dosage and duration should always be determined by a qualified healthcare professional based on individual patient needs and blood test results. Jakafi 10mg Tablets contain ruxolitinib, a Janus kinase (JAK) inhibitor used to treat certain blood disorders and immune-related conditions.
Jakafi Tablets Key Benefits:
Helps manage myelofibrosis symptoms by reducing abnormal blood cell signaling.
May help reduce enlarged spleen size associated with myelofibrosis.
Helps improve disease-related symptoms such as spleen discomfort and fatigue in some patients.
Supports treatment of polycythemia vera (PV) in adults who do not respond adequately to hydroxyurea.
Helps control overactive JAK1/JAK2 pathways involved in blood cell production and immune responses.
May be used for certain cases of acute or chronic graft-versus-host disease (GVHD) under specialist supervision.
Provides targeted therapy that works on specific disease-related pathways rather than acting as traditional chemotherapy.
How Jakafi Tablets Works:
Jakafi 10Mg Tablets work by containing Ruxolitinib, a targeted Janus kinase (JAK) inhibitor that blocks the activity of JAK1 and JAK2 enzymes. These enzymes play an important role in controlling signals involved in blood cell production, immune response, and inflammation. By inhibiting JAK1/JAK2 pathways, Jakafi helps reduce abnormal signaling that contributes to conditions such as myelofibrosis, polycythemia vera, and certain graft-versus-host disease (GVHD) cases. This action may help control excessive blood cell activity, reduce inflammation, improve disease-related symptoms, and decrease spleen enlargement in some patients. Slow Down Abnormal Blood Cell Production Reduce Inflammation Improve Symptoms Like Fatigue, Spleen Enlargement, And Itching.
Jakafi Tablets How To Use:
Follow Prescription. Take The Tablet Orally, Usually Twice Daily, Or As Directed By Your Healthcare Provider.
Swallow Whole. Take The Tablet With Water.do Not Crush, Chew, Or Break The Tablet, As It May Affect Absorption.
Consistency. Take At The Same Times Each Day To Maintain Steady Blood Levels.can Be Taken With Or Without Food.
Monitor Your Health. Report Any Unusual Symptoms Such As Fever, Bruising, Or Infections To Your Doctor Immediately.
Do Not Miss Doses. If You Miss A Dose, Take It As Soon As You Remember Unless It Is Almost Time For The Next Dose.
Storage. Store In A Cool, Dry Place Away From Direct Sunlight.keep Out Of Reach Of Children.
